Marshall Wace, LLP Trinity Biotech PLC Transaction History

Marshall Wace, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.43 - $2.25 $49,625 - $78,081	-34,703 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.82 - $2.94 $37,954 - $61,310	-20,854 Reduced 37.54%	34,703 $75,000
Q2 2021 Aug 13, 2021	SELL	$2.77 - $4.18 $97,290 - $146,814	-35,123 Reduced 38.73%	55,557 $163,000
Q1 2021 May 17, 2021	BUY	$3.26 - $6.64 $295,616 - $602,115	90,680 New	90,680 $341,000

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $46.5M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.